Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tauropace Reduces Infection After Cardiac Electronic Implantable Device Implantation in Heart Failure Patients

NCT05103267 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT05103267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05103267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tauropace Reduces Infection After Cardiac Electronic Implantable Device Implantation in Heart Failure Patients
Lead sponsor
Federico II University
Phase
Observational
Overall status
Unknown status
Start date
June 6, 2022
Completion date
June 6, 2024
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac implantable electronic device infections, heart failure, high risk, infection cardiac